EPH Receptor A7 (EPHA7) (C-Term) Peptide
Quick Overview for EPH Receptor A7 (EPHA7) (C-Term) Peptide (ABIN976381)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Sequence
- SNQDVIKAIE EGYRLPAPMD CPAGLHQLML DCWQKERAER PKFEQIVGIL
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-EPHA7 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- EPH Receptor A7 (EPHA7)
-
Background
-
This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands.
Alias Symbols: EHK3, HEK11
Protein Size: 998 -
Molecular Weight
- 112 kDa
-
Gene ID
- 2045
-
NCBI Accession
- NM_004440, NP_004431
-
UniProt
- Q15375
Target
-